Portal de Periódicos da CAPES

GnRH Analogues in Ovarian Stimulation

1991; Wiley; Volume: 626; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1991.tb37919.x

1749-6632

Keith Gordon, Gary D. Hodgen,

Assisted Reproductive Technology and Twin Pregnancy

Annals of the New York Academy of SciencesVolume 626, Issue 1 p. 238-249 GnRH Analogues in Ovarian Stimulation KEITH GORDON, KEITH GORDON The Jones Institute for Reproductive Medicine Eastern Virginia Medical School Department of Obstetrics and Gynecology Norfolk, Virginia 23510Search for more papers by this authorGARY D. HODGEN, GARY D. HODGEN The Jones Institute for Reproductive Medicine Eastern Virginia Medical School Department of Obstetrics and Gynecology Norfolk, Virginia 23510Search for more papers by this author KEITH GORDON, KEITH GORDON The Jones Institute for Reproductive Medicine Eastern Virginia Medical School Department of Obstetrics and Gynecology Norfolk, Virginia 23510Search for more papers by this authorGARY D. HODGEN, GARY D. HODGEN The Jones Institute for Reproductive Medicine Eastern Virginia Medical School Department of Obstetrics and Gynecology Norfolk, Virginia 23510Search for more papers by this author First published: June 1991 https://doi.org/10.1111/j.1749-6632.1991.tb37919.xCitations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Lopata, A. 1983. Concepts in human in vitro fertilization and embryo transfer. Fertil. Steril. 40: 289. 2 Craft, I., R. Porter, S. Green, M. Tucker, B. Smith, H. Twigg, K. Ahuja & D. Whittingham. 1984. Success of fertility, embryo number and in vitro fertilization. Lancet I: 732. 3 Wood, C., R. McMaster, G. Rennie, A. Trounson & J. Leeton. 1985. Factors influencing pregnancy rates following in vitro fertilization and embryo transfer. Fertil. Steril. 43: 245. 4 Greenblatt, R. B., W. E. Barfield, E. C. Jungck & A. W. Ray. 1961. Induction of ovulation with MRL/41. JAMA 178: 101. 5 Trounson, A. O., J. F. Leeton, C. Wood, C. Webb, J. Webb & J. Wood. 1981. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 212: 681. 6 Gemzell, C. A., E. Diczfalusy & G. Tillinger. 1958. Clinical effect of human pituitary follicle-stimulating hormone (FSH). J. Clin. Endocrinol. Metab. 18: 1333. 7 Wu, C. H. 1978. Monitoring of ovulation induction. Fertil. Steril. 30: 617. 8 Garcia, J. E., G. S. Jones, A. A. Acosta & G. Wright, Jr. 1983. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase I, 1981. Fertil. Steril. 39: 167. 9 Garcia, J. E., G. S. Jones, A. A. Acosta & G. Wright, Jr. 1983. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase II, 1981. Fertil. Steril. 39: 174. 10 Hull, M. G. R., U. A. Knuth, M. A. F. Murray & H. S. Jacobs. 1979. The practical value of the progestogen challenge test, serum oestradiol estimation or clinical examination in assessment of the oestrogen state and response to clomiphene in amenorrhoea. Br. J. Obstet. Gynecol. 86: 799. 11 Ellis, J. D. & J. G. Williamson. 1975. Factors influencing the pregnancy and complication rates with human menopausal gonadotrophin therapy. Br. J. Obstet. Gynecol. 82: 52–57. 12 Fleming, R., A. H. Adam, D. H. Barlow, W. P. Black, M. C. MacNaughton & J. R. T. Coutts. 1982. A new systematic treatment for infertile women with abnormal hormone profiles. Br. J. Obstet. Gynecol. 89: 80. 13 Kenigsberg, D., B. A. Littman & G. D. Hodgen. 1984. Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist. Fertil. Steril. 42: 112. 14 Kenigsberg, D., B. A. Littman, R. F. Williams & G. D. Hodgen. 1984. Medical hypophysectomy: II. Variability of ovarian response to gonadotropin therapy. Fertil. Steril. 42: 116. 15 Porter, R. N., W. Smith, I. L. Craft, N. A. Abdulwahid & H. S. Jacobs. 1984. Induction of ovulation for in vitro fertilisation using Buserelin and gonadotropins. Lancet II: 1284. 16 Meldrum, D. 1989. GnRH agonists as adjuncts for in vitro fertilization. Obstet. Gynecol. Surg. 44: 314. 17 Matsuo, H., Y. Baba, R. M. G. Nair, A. Arimura & A. V. Schally. 1971. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun. 43: 1334. 18 Baba, Y., H. Matsuo & A. V. Schally. 1971. Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses. Biochem. Biophys. Res. Commun. 44: 459. 19 Burgus, R., M. Butcher, M. Amoss, N. Ling, M. Monahan, J. Rivier, R. Fellows, R. Blackwell, W. Vale & R. Guillemin. 1972. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc. Natl. Acad. Sci. USA 69: 278. 20 King, J. A. & R. P. Millar. 1979. Heterogeneity of vertebrate luteinizing hormone-releasing hormone. Science 206: 67. 21 King, J. A. & R. P. Millar. 1980. Comparative aspects of luteinizing hormone-releasing hormone structure and function in vertebrate phylogeny. Endocrinology 106: 707. 22 Knobil, E. 1980. The neuroendocrine control of the menstrual cycle. Recent Prog. Horm. Res. 36: 53. 23 Belchetz, P. E., T. M. Plant, Y. Nakai, E. J. Keogh & E. Knobil. 1978. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202: 631. 24 Wildt, L., G. Marshall & E. Knobil. 1980. Experimental induction of puberty in the infantile female rhesus monkey. Science 207: 1373. 25 Crowley, W. F. & J. W. McArthur. 1980. Stimulation of the normal menstrual cycle in Kallmann's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J. Clin. Endocrinol. Metab. 51: 173. 26 Pimstone, B., S. Epstein, S. M. Hamilton, D. Le Roith & S. Hendricks. 1977. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin-releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J. Clin. Endocrinol. Metab. 44: 356. 27 Barron, J. L., R. P. Millar & D. Searle. 1982. Metabolic clearance and plasma half-disappearance time of d-Trp6 and exogenous luteinizing hormone-releasing hormone. J. Clin. Endocrinol. Metab. 54: 1169. 28 Handelsman, D. J. & R. S. Swerdloff. 1986. Pharmacokinetics of gonadotropin-releasing hormone and its analogs. Endocrinol. Rev. 7: 95. 29 Filicori, M., N. Santoro, G. R. Merriam & W. F. Crowley, Jr. 1986. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 62: 1136. 30 Ling, N., S.-Y. Ying, N. Ueno, S. Shimasaki, F. Esch, M. Hotta & R. Guillemin. 1986. Pituitary FSH is released by a heterodimer of the β-subunits for the two forms of inhibin. Nature 321: 779. 31 Lumpkin, M. D., J. H. Moltz, W. H. Yu, W. K. Samson & S. M. McCann. 1987. Purification of FSH-releasing factor: Its dissimilarity from LHRH of mammalian, avian, and piscian origin. Brain Res. Bull. 18: 175. 32 Vale, W., J. Rivier, J. Vaughan, R. McClintock, A. Corrigan, W. Woo, D. Karr & J. Spiess. 1986. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776. 33 Meldrum, D. R., Z. Tsao, S. E. Monroe, G. D. Braunstein, J. Sladek, J. K. H. Lu, W. Vale, J. Rivier, H. L. Judd & R. J. Chang. 1984. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J. Clin. Endocrinol. Metab. 58: 755. 34 Werlin, L. B. & G. D. Hodgen. 1983. Gonadotropin-releasing hormone agonist suppresses ovulation, menses and endometriosis in monkeys: An individualized intermittent regimen. J. Clin. Endocrinol. Metab. 56: 844. 35 Hodgen, G. D. 1987. On the management of orchids by gonadotropin-releasing hormone agonist therapy. Fertil. Steril. 48: 914. 36 Parinaud, J., A. Beaur, E. Bourreau, G. Vieitez & G. Pontonnier. 1988. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil. Steril. 50: 597. 37 Karten, M. J. & J. E. Rivier. 1986. Gonadotropin-releasing hormone analog design. Structure-function studies towards the development of agonists and antagonists: Rationale and perspective. Endocrinol. Rev. 7: 44. 38 Schmidt, F., K. Sundaram, R. B. Thau & C. W. Bardin. 1984. [Ac-d-Nal(2)1, 4F-d-Phe2, d-Trp3, d-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception 29: 283. 39 Leal, J. A., R. F. Williams, D. R. Danforth, K. Gordon & G. D. Hodgen. 1988. Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist. J. Clin. Endocrinol. Metab. 67: 1325. 40 Leal, J. A., K. Gordon, R. F. Williams, D. R. Danforth, S. Roh & G. D. Hodgen. 1989. Probing studies on multiple dose effects of Antide (Nal-Lys) GnRH antagonist in ovariectomized monkeys. Contraception 40: 623. 41 Danforth, D. R., K. Gordon, J. A. Leal, R. F. Williams & G. D. Hodgen. 1990. Extended presence of Antide (Nal-Lys antagonist) in circulation: Prolonged duration of gonadotropin inhibition may derive from Antide binding to serum proteins. J. Clin. Endocrinol. Metab. 70: 548. 42 Gordon, K., R. F. Williams, D. R. Danforth & G. D. Hodgen. 1990. A novel regimen of GnRH antagonist plus pulsatile GnRH: Controlled restoration of gonadotropin secretion and ovulation induction. Fertil. Steril. 54: 1140. 43 Talbert, L. M. 1988. Endogenous luteinizing hormone surge and superovulation. Fertil. Steril. 49: 24. 44 Droesch, K., S. J. Muasher, R. G. Brzyski, G. S. Jones, S. Simonetti, H.-C. Liu & Z. Rozenwaks. 1989. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil. Steril. 51: 292. 45 Sathanandan, M., G. M. Warnes, C. A. Kirby, O. M. Petrucco & C. D. Mathews. 1989. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer. Fertil. Steril. 51: 998. 46 Ashkenazi, J., D. Dicker, D. Feldberg, G. A. Goldman, A. Yeshaya & J. A. Goldman. 1989. The value of GnRH analogue therapy in IVF in women with unexplained infertility. Hum. Reprod. 6: 667. 47 Caspi, E., R. Ron-El, A. Golan, H. Nachum, A. Herman, Y. Soffer & Z. Weinraub. 1989. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog d-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil. Steril. 51: 95. 48 Katayama, K. P., M. Roesler, C. Gunnarson, E. Stehlik & S. Jagusch. 1988. Short-term use of gonadotropin-releasing hormone agonist (Leuprolide) for in vitro fertilization. J. IVF-ET 5: 332. 49 Meldrum, D. R., A. Wiscot, F. Hamilton, A. L. Gutlay, D. Huynh & W. Kempton. 1988. Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil. Steril. 50: 400. 50 Palermo, R., G. Amodeo, D. Navot, Z. Rosenwaks & E. Cittadini. 1988. Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles. Fertil. Steril. 49: 290. 51 Cheskowski, R. J., L. R. Kruse & T. E. Nass. 1989. Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. Fertil. Steril. 52: 250. 52 Zorn, J. R., P. Boyer & A. Guichard. 1987. Never on Sunday: Programming for IVF-ET and GIFT. Lancet I: 386. 53 Muasher, S. J., S. Oehninger, S. Simonetti, J. Matta, L. M. Ellis, H.-C. Liu, G. S. Jones & Z. Rosenwaks. 1988. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil. Steril. 50: 298. 54 Fleming, R. & J. R. T. Courtts. 1988. LHRH analogues for ovulation induction, with particular reference to polycystic ovary syndrome. Baillière's Clin. Obstet. Gynaecol. 2: 677. 55 Hodgen, G. D. 1983. Surrogate embryo transfer combined with estrogen-progesterone therapy in ovariectomized monkeys: Implantation, gestation, and delivery without ovaries. JAMA 250: 2167. 56 Lutjen, P., A. Trounson, J. Leeton, J. Findlay, C. Wood & P. Renou. 1984. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature (London) 307: 174. 57 Schmidt, C. L., D. Van Ziegler & C. L. Gagliardi. 1989. Transfer of cryopreservedthawed embryos: The natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP). Fertil. Steril. 52: 609. 58 Zorn, J.-R., M. Barata, C. Brami, S. Epelboin, C. Nathan, G. Papageorgiou, P. Quantin, F. Rolet, M. Savale, P. Boyer, A. Guichard, L. Cedard, A.-M. Comaru-Schally & A. V. Schally. 1988. Ovarian stimulation for in vitro fertilization combining administration of gonadotropins and blockade of the pituitary with d-Trp6-LHRH microcapsules: Pilot studies with two protocols. Hum. Reprod. 3: 235. 59 Sharma, V., J. Williams, W. Collins, A. Riddle, B. Mason & M. Whitehead. 1988. The sequential use of a luteinizing hormone-releasing hormone (LH/RH) agonist and human menopausal gonadotropins to stimulate folliculogenesis in patients with resistant ovaries. J. IVF-ET 5: 38. 60 Gronow, M. J., M. J. Martin, D. Hay, D. Moro & J. B. Brown. 1985. The luteal phase after hyperstimulation for in vitro fertilization. Ann. N.Y. Acad. Sci. 442: 391. 61 Sopelak, V. M. & G. D. Hodgen. 1987. Infusion of gonadotropin-releasing hormone agonist (GnRH-Ag) during pregnancy: Maternal and fetal response in primates. Am. J. Obstet. Gynecol. 156: 755. 62 Remorgida, V., P. Anserini, S. Croce, M. Costa, A. Ferraiolo, A. Centonze, G. Gaggero & G. L. Capitanio. 1989. The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program. J. IVF-ET 6: 76. 63 Vauthier, D. & G. Lefebvre. 1989. The use of gonadotropin-releasing hormone analogs for in vitro fertilization comparison between the standard form and long-acting formulation of d-Trp-6-luteinizing hormone-releasing hormone. Fertil. Steril. 51: 100. 64 Hodgen, G. D. 1990. Uses of GnRH analogues in IVF/GIFT. Contemp. Obstet. Gynecol. 35: 10. Citing Literature Volume626, Issue1Frontiers in Human ReproductionJune 1991Pages 238-249 ReferencesRelatedInformation